.png)
.webp)
Alex Grass, the visionary founder of Rite Aid, served as CEO from the company's inception in 1962 until 1995—overseeing its growth from a single store in Scranton, Pennsylvania, to a major player in the retail pharmacy industry.
Under his leadership, Rite Aid expanded rapidly, acquiring numerous regional drug store chains and becoming the first drugstore chain to reach $1 billion in sales in 1983.
However, Grass's tenure was not without controversy, as he faced criticism for his allegedly autocratic management style and the company's involvement in a price-fixing scandal in the late 1980s.
Despite these challenges, Grass's entrepreneurial spirit and strategic acquisitions laid the foundation for Rite Aid's future success, cementing his legacy as a key figure in the company's history.
Martin Grass, son of founder Alex Grass, took over as CEO of Rite Aid in 1995—inheriting a company that had grown significantly under his father's leadership.
During his tenure, Martin Grass continued the company's expansion strategy, acquiring Thrifty PayLess in 1996, which added over 1,000 stores to Rite Aid's portfolio and expanded its presence on the West Coast.
However, his leadership was marred by scandal when he was accused of financial misconduct, including falsifying financial statements and engaging in fraudulent accounting practices.
These legal troubles led to a significant restructuring of the company, with Grass resigning as CEO in 1999 and ultimately serving a six-year prison sentence for his role in the accounting fraud scandal, marking a tumultuous end to his time at the helm of Rite Aid.
Robert Miller took over as CEO of Rite Aid in 1999, facing the daunting task of revitalizing the company in the wake of the Grass family's legal troubles and the resulting financial instability.
Miller implemented a comprehensive turnaround strategy, focusing on improving operational efficiency, closing underperforming stores, and restructuring the company's debt.
Under his leadership, Rite Aid established a new corporate governance structure and worked to restore investor confidence by increasing transparency and accountability.
While Miller's tenure was relatively short, his efforts to stabilize the company and lay the groundwork for future growth were crucial in helping Rite Aid recover from the scandals that had plagued it in the late 1990s.
Mary Sammons took the helm of Rite Aid in 2003, drawing from her prior leadership at Fred Meyer.
She spearheaded Rite Aid's largest expansion in 2007, when the company purchased Brooks and Eckerd drugstores for $3.4 billion.
This move added 1,800 locations and cemented Rite Aid's spot as America's third-largest drugstore chain.
To reshape the customer experience, Sammons launched "Customer World"—a focused push to modernize stores and elevate service standards.
Her tenure marked peak growth for Rite Aid. By 2008, the company operated 5,000 stores with 112,000 employees.
This expansion strengthened Rite Aid's market position against fierce retail pharmacy competition.
John Standley took the reins as CEO of Rite Aid in 2010, succeeding Mary Sammons and inheriting a company that had undergone significant expansion in the preceding years.
Under Standley's leadership, Rite Aid continued to grow, acquiring the pharmacy benefit manager Envision Rx in 2015 for $2 billion, which helped to diversify the company's revenue streams.
However, Standley also faced significant financial challenges during his tenure, as Rite Aid struggled with declining sales and increased competition from larger rivals like CVS and Walgreens.
In 2015, Walgreens announced plans to acquire Rite Aid for $9.4 billion, but the deal faced regulatory scrutiny and was ultimately terminated in 2017, with Walgreens instead agreeing to purchase 1,932 Rite Aid stores for $4.38 billion.
The aftermath of the failed merger left Rite Aid in a weakened financial position, and despite Standley's efforts to turn the company around, including closing underperforming stores and implementing cost-cutting measures, the company continued to face challenges, ultimately leading to his departure in 2019.
Heyward Donigan took over as CEO of Rite Aid in 2019, facing the challenging task of turning around the company's fortunes after a period of financial struggles and the aftermath of the failed merger with Walgreens.
Donigan brought a fresh perspective to the role, having previously served as CEO of Sapphire Digital, a healthcare technology company.
Under her leadership, Rite Aid focused on modernizing its stores, expanding its healthcare offerings, and investing in technology to improve the customer experience and streamline operations.
However, despite these efforts, the company continued to face significant headwinds, including increased competition, declining sales, and the ongoing impact of the COVID-19 pandemic.
In early 2023, Donigan abruptly resigned from her position as CEO, citing personal reasons, leaving the company in a state of uncertainty and transition as it sought to navigate the challenging retail pharmacy landscape.
Elizabeth Burr stepped into the role of interim CEO at Rite Aid in January 2023, following the abrupt resignation of Heyward Donigan.
As a seasoned executive with extensive experience in the healthcare industry, Burr was tasked with guiding the company through a period of transition and uncertainty.
During her ten-month tenure as interim CEO, Burr focused on maintaining stability within the organization, implementing cost-saving measures, and exploring strategic options to address Rite Aid's ongoing financial challenges.
She also had to navigate the company through the early stages of its preparations for a potential bankruptcy filing, as Rite Aid grappled with a heavy debt load and mounting legal challenges related to the opioid crisis.
While Burr's role was temporary, her leadership during this critical period helped to lay the groundwork for the company's future direction and the appointment of a permanent CEO in October 2023.
Jeffrey Stein took control of Rite Aid in October 2023 as both CEO and Chief Restructuring Officer.
His background centers on reviving struggling companies and managing corporate debt.
Rite Aid faced three critical challenges when Stein stepped in: mounting costs from opioid-related lawsuits, overwhelming debt, and the urgent need for business transformation.
Within weeks of his arrival, Stein led Rite Aid into Chapter 11 bankruptcy protection.
As Chief Restructuring Officer, he now leads talks with lenders to reduce the company's debt while crafting a viable path through bankruptcy.
His CEO duties extend beyond the financial realm.
Stein manages Rite Aid's stores and operations, launches initiatives to boost revenue, and works to restore confidence among key stakeholders—from store employees to suppliers.
This dual role positions Stein to reshape both Rite Aid's finances and its fundamental business model.
While bankruptcy marks a difficult chapter for the pharmacy chain, Stein's track record in corporate turnarounds offers a blueprint for recovery.
Matt Schroeder was appointed as CEO of Rite Aid in September 2024 after the company emerged from Chapter 11 bankruptcy.
Prior to becoming CEO, Schroeder had been with Rite Aid since 2000, serving most recently as Executive Vice President and Chief Financial Officer where he managed the company's financial operations, store development, and procurement functions.
Under his initial leadership as CEO, Rite Aid transitioned to become a private company owned by creditors, eliminated $2 billion in debt, and secured $2.5 billion in exit financing while operating approximately 1,700 retail pharmacy locations across 16 states.
.png){kind=logo}
.webp)
.webp)
.webp)